Skip to main content
OpenTrials

Clinical trial condition

Relapsed and Refractory Follicular Lymphoma

Explore clinical trials studying Relapsed and Refractory Follicular Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Relapsed and Refractory Follicular Lymphoma trial results

Recruiting

Orelabrutinib Plus Rituximab Followed by Maintenance With Orelabrutinib for Relapsed and Refractory Follicular Lymphoma(RR FL)

NCT04989621

Conditions
Disease Attributes, Follicular Lymphoma, Hemic and Lymphatic Diseases, +13 more
Locations
  • Guangdong General Hospital Guangzhou, Guangdong, China
  • Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
  • Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University, Guangzhou, Guangdong, China
View Trial Details

Related conditions